First Trust Investment Solutions L.P. Vertex Pharmaceuticals Inc Transaction History
First Trust Investment Solutions L.P.
- $888 Billion
- Q3 2024
A detailed history of First Trust Investment Solutions L.P. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, First Trust Investment Solutions L.P. holds 438 shares of VRTX stock, worth $179,864. This represents 0.02% of its overall portfolio holdings.
Number of Shares
438
Previous 427
2.58%
Holding current value
$179,864
Previous $200 Million
1.78%
% of portfolio
0.02%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding VRTX
# of Institutions
1,724Shares Held
221MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$11 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$9.51 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.75 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.85 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$3.7 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $105B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...